CTC researchers and their collaborators have a strong record of published research in prestigious international journals. Recent journal articles are listed here.
Follow the link to find specific articles, or articles by year, author, trial or group, back to 2005.
Search for articles
Alexandre J, Brown C, Coeffic D, Raban N, Pfisterer J, Maenpaa J, Chalchal H, Fitzharris B, Volgger B, Vergote I, Pisano C, Ferrero A, Pujade-Lauraine E. CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial. British Journal of Cancer 2012; 106 (4)
Baker J, Obermair A, Gebski V, Janda M. Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and systematic review of the literature. Gynecologic Oncology 2012; 125:263–270.
Best JD, Drury PL, Davis TME, Taskinen MR, Kesäniemi YA, Scott R, Pardy C, Voysey M, Keech AC, on behalf of the FIELD study investigators. Glycemic control over 5 years in 4900 people with type 2 diabetes: real-world diabetes therapy in a clinical trial cohort. Diabetes Care 2012;
Blinman P, King M, Norman R, Viney R, Stockler MR. Preferences for cancer treatments: an overview of methods and applications in oncology. Annals of Oncology 2012;
Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, Simes RJ, Durrington P, Hitman GA, Welch KM, DeMicco DA, Zwinderman AH, Clearfield MB, Downs JR, Tonkin AM, Colhoun HM, Gotto AM, Ridker PM, Kastelein JJ. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA 2012; 307 (12) :1302–1309.
Brundage M, Gropp M, Mefti F, Mann K, Lund B, Gebski V, Wolfram G, Reed N, Pignata S, Ferrero A, Brown C, Eisenhauer E, Pujade-Lauraine E. Health-related quality of life in recurrent platinum-sensitive ovarian cancer—results from the CALYPSO trial. Annals of Oncology 2012;
Chirgwin J, Sun Z, Smith I, Price KN, Thürlimann B, Ejlertsen B, Bonnefoi H, Regan MM, Goldhirsch A, Coates AS, for the BIG 1-98 Collaborative and International Breast Cancer Study Groups. The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Breast Cancer Research and Treatment 2012; 131:295-306.
Cholesterol Treatment Trialists’ (CTT) Collaboration,, Emberson JR, Kearney PM, Blackwell L, Newman C, Reith C, Bhala N, Holland L, Peto R, Keech A, Collins R, Simes J, Baigent C. Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175 000 people in 27 randomised trials of statin therapy. PLoS One 2012; 7 (1) :e29849.
Coburn N, Beldham-Collins R, Westling J, Trovato J, Gebski V. Evaluation of flexible and rigid (class solution) radiation therapy conformal prostate planning protocols. Medical Dosimetry 2012; 37 (1) :5–8.
Dear RF, Barratt AL, Askie LM, Butow PN, McGeechan K, Crossing S, Currow DC, Tattersall MH. Impact of a cancer clinical trials web site on discussions about trial participation: a cluster randomized trial. Annals of Oncology 2012;
Dietz HP, Franco AV, Shek KL, Kirby A. Avulsion injury and levator hiatal ballooning: two independent risk factors for prolapse? An observational study. Acta Obstetricia et Gynecologica Scandinavica 2012; 91:211-214.
Gebski V, Ellingson K, Edwards J, Jernigan J, Kleinbaum D. Modelling interrupted time series to evaluate prevention and control of infection in healthcare. Epidemiology and Infection 2012;
Goldstein D Spry N, Cummins MM, Brown C, van Hazel GA, Carroll S, Selva-Nayagam S, Borg M, Ackland SP, Wratten C, Shapiro J, Porter IWT, Hruby G, Horvath L, Bydder S, Undercill C, Harvey J, Gebski VJ, on behalf of the Australasian Gastro-Intestinal Trials Group. The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine–oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer . British Journal of Cancer 2012; 106 (1) :61-69.
Kiely B, Stockler M. Meta-analysis: adjuvant tamoxifen reduces recurrence and death at 15 years in ER-positive early breast cancer (review). ACP Journal Club (Annals of Internal Medicine) 2012; 156 (6) :JC3–4.
Kifley A, Heller GZ, Beath KJ, Bulger D, Ma J, Gebski V. Multilevel latent variable models for global health-related quality of life assessment. Statistics in Medicine 2012;
King MT, Viney R, Smith DP, Hossain I, Street D, Savage E, Fowler S, Berry MP, Stockler M, Cozzi P, Stricker P, Ward J, Armstrong BK. Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer. British Journal of Cancer 2012; 106 (4) :638–645.
Koczwara B, Barton MB, Walpole ET, Grimison P, Blinman PL, Crossing S, Francis K. Workforce shortages in medical oncology: a looming threat to quality cancer care. Medical Journal of Australia 2012; 196 (1) :32-33.
Kondalsamy-Chennakesavan S, Janda M, Gebski V, Baker J, Brand A, Hogg R, Jobling TW, Land R, Manolitsas T, Nascimento M, Neesham D, Nicklin JL, Oehler MK, Otton G, Perrin L, Salfinger S, Hammond I, Leung Y, Sykes P, Ngan H, Garrett A, Laney M, Ng TY, Tam K, Chan K, Wrede DH, Pather S, Simcock B, Farrell R, Robertson G, Walker G, McCartney A, Obermair A. Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: results from a randomised controlled trial. European Journal of Cancer 2012;
Lee CK, Marschner I, Simes J, Voysey M, Egleston BL, Hudes G, de Souza PL. Increase in cholesterol predicts survival advantage in renal cell carcinoma patients treated with temsirolimus. Clinical Cancer Research 2012;
Marschner IC, Gillett AC. Relative risk regression: reliable and flexible methods for log-binomial models. Biostatistics 2012; 13 (1) :179-192.
Marschner IC, Gillett AC, O’Connell RL. Stratified additive Poisson models: computational methods and applications in clinical epidemiology. Computational Statistics and Data Analysis 2012; 56 (5) :1115–1130.
Passey ME, Shreshtha RN, Bertram MY, Schofield DJ, Vos T, Callander EJ, Percival R, Kelly SJ. The impact of diabetes prevention on labour force participation and income of older Australians: an economic study. BMC Public Health 2012; 12 (16)
Ranjan AK, Joglekar MV, Atre AN, Patole M, Bhonde RR, Hardikar AA. Cellular detection of multiple antigens at single cell resolution using antibodies generated from the same species. Journal of Immunological Methods 2012; 379 (1-2) :42–47.
Schofield D, Kelly S, Shrestha R, Callander E, Passey M, Percival R. The impact of back problems on retirement wealth. Pain 2012; 153 (1) :203-210.
Schofield DJ, Callander EJ, Shrestha RN, Percival R, Kelly SJ, Passey ME . Letter to the editor regarding Kawada's comments on the paper labour force participation and the influence of having CVD on income poverty of older workers [letter]. International Journal of Cardiology 2012;
Schofield DJ, Kelly S, Shrestha R, Passey M, Callander E, Percival R. The long term financial impacts of CVD: living standards in retirement. International Journal of Cardiology 2012; 155 (3) :406–408.
Schofield DJ, Shrestha RN, Callander EJ. Access to general practitioner services amongst underserved Australians: a microsimulation study. Human Resources for Health 2012; 10 (1) :1.
Staub LP, Dyer S, Lord SJ, Simes RJ. Linking the evidence: intermediate outcomes in medical test assessments. International Journal of Technology Assessment in Health Care 2012; 28 (1) :52–58.
Staub LP, Lord SJ, Simes J, Dyer S, Houssami N, Chen RY, Irwig L. Using patient management as a surrogate for patient health outcomes in diagnostic test evaluation. BMC Medical Research Methodology 2012; 12 (1) :12.
Stockler MR, Wilcken NR. Why Is management of cancer pain still a problem? [editorial]. Journal of Clinical Oncology 2012;
Surjana D, Halliday GM, Martin A, Moloney FJ, Damian DL. Oral nicotinamide reduces actinic keratoses in phase 2 double-blinded randomized controlled trials. Journal of Investigative Dermatology 2012;
Suttie CF, Hong A, Stalley P, Veillard AS, Tattersall MH. Does chemotherapy shorten the latency interval of radiation-induced sarcomas? [research letter]. Clinical Oncology (Royal College of Radiologists). 2012; 24:77-89.
Ting RD, Keech AC, Drury PL, Donoghoe MW, Hedley J, Jenkins AJ, Davis TME, Lehto S, Celermajer D, Simes RJ, Rajamani K, Stanton K, for the FIELD study investigators. Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment. Diabetes Care 2012; 35 (2) :218-225.
Tonkin A, Hunt MD, Voysey M, Kesäniemi A, Hamer A, Waites J, Mahar L, Mann S, Glasziou P, Forder P, Simes J, Keech AC, on behalf of the FIELD study investigators. Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. American Heart Journal 2012; 163 (3) :508–514.
Venkateswaran LP, Butow PN, Jansen J, Wilcken NR, Wong MK, Hui R, Szonyi G, Gebski VJ, Naganathan V, Horvath LG, Tattersall MH. Decision making in older patients with advanced cancer: does doctor know best? [letter]. Medical Journal of Australia 2012; 196 (1) :35-36.
Verry H, Lord SJ, Martin A, Gill G, Lee CK, Howard K, Wetzig N, Simes J. Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis. British Journal of Cancer 2012; 106 (6) :1045–1052.
Walter SD, Macaskill P, Lord SJ, Irwig L. Effect of dependent errors in the assessment of diagnostic or screening test accuracy when the reference standard is imperfect. Statistics in Medicine 2012;
Weickhardt AJ, Price TJ, Chong G, Gebski V, Pavlakis N, Johns TG, Azad A, Skrinos E, Fluck K, Dobrovic A, Salemi R, Scott AM, Mariadason JM, Tebbutt NC. Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancer. Journal of Clinical Oncology 2012;
Whalley D, Patanjali N, Jackson M, Lovett A, Chatfield M, Hruby G. HDR brachytherapy combined with external beam radiation for localised prostate cancer: early experience from the Sydney Cancer Centre. Journal of Medical Imaging and Radiation Oncology 2012; 56 (2) :220–226.
Wong MH, Stockler MR, Pavlakis N. Bisphosphonates and other bone agents for breast cancer. Cochrane Database of Systematic Reviews 2012; 2:CD003474.
